What is the market doing?
What the tape says about BBIO
BridgeBio Pharma, Inc. is +73% over the past year while the S&P 500 is +23%: 50 points ahead of the market.
+73%
1-year return · S&P 500 +23%
- vs 200-day average
- +9.6%
vs 200-day average · close to trend
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- −7.6%
Below its 52-week high
Details›
- Last close2026-08-26
- $79.37
- 1 monthS&P 500 +3.7%
- −4.3%
- 1 yearS&P 500 +23%
- +73%
- 5 yearsS&P 500 +87%
- +52%
- vs 50-day average$76.68
- +3.5%
- 52-week high
- $85.86
- 52-week low
- $46.58
- Annualised volatility
- 53%
| Year | Return |
|---|---|
| 2026 (year to date) | +3.8% |
| 2025 | +179% |
| 2024 | −32% |
| 2023 | +430% |
| 2022 | −54% |
| 2021 | −77% |
| 2020 | +103% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 7 | 3 of 7 | −4.3% |
| Feb | 7 | 3 of 7 | +0.96% |
| Mar | 7 | 3 of 7 | +7.8% |
| Apr | 7 | 2 of 7 | −6.8% |
| May | 7 | 2 of 7 | −3.8% |
| Jun | 7 | 6 of 7 | +13% |
| Jul | 8 | 5 of 8 | +15% |
| Aug | 8 | 5 of 8 | +2.5% |
| Sep | 7 | 2 of 7 | −5.1% |
| Oct | 7 | 5 of 7 | +4.2% |
| Nov | 7 | 5 of 7 | +10% |
| Dec | 7 | 5 of 7 | +4.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.